April 2019 CMDh press release









Angiotensin-II- receptor antagonists (sartans) containing a tetrazole

5 mars 2021 ... the outcome of the Article 31 referral on angiotensin-II-receptor antagonists (sartans) containing a tetrazole group (EMEA/H/A-31/1471).
angiotensin ii receptor antagonists sartans article referral questions answers implementation en


Sartans Art 31 - assessment report

14 févr. 2019 Referral under Article 31 of Directive 2001/83/EC angiotensin-II-receptor antagonists (sartans) containing a tetrazole group.
angiotensin ii receptor antagonists sartans article referral chmp assessment report en


Sartans Art 31 - CHMP assessment - impact Nitrosamines Art 5(3

12 nov. 2020 2001/83/EC for angiotensin-II-receptor antagonists (sartans) containing ... Article 31 referral procedure on sartans with a tetrazole ring .
angiotensin ii receptor antagonists sartans article referral chmp assessment report impact en


CMDh Questions & Answers on implementation of outcome of Art

In October 2020 the CHMP concluded that the outcome of the Article 31 referral on angiotensin-II- receptor antagonists (sartans) containing a tetrazole group ( 
valsartan ? blob=publicationFile





Nitrosamines: EMA aligns recommendations for sartans with those

13 nov. 2020 Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 ... sartans (also known as angiotensin-II-receptor antagonists).
angiotensin ii receptor antagonists sartans article referral nitrosamines ema aligns en


Angiotensin-II- receptor antagonists (sartans) containing a tetrazole

The key issue of this referral concerns the detection of N-nitrosamine (esp. The CHMP considered the procedure under Article 31 of Directive 2001/83/EC ...
angiotensin ii receptor antagonists sartans article referral annex i en


Valsartan EMEA/H/A-31/1471

16 juil. 2018 Referral under Article 31 of Directive 2001/83/EC ... Valsartan is an angiotensin-II-receptor antagonist authorised in the EU as a single ...
angiotensin ii receptor antagonists sartans article referral chmp list questions be addressed api en


Angiotensin-II- receptor antagonists (sartans) containing a tetrazole

17 avr. 2019 On 31 January 2019 EMA recommended that companies making sartan blood pressure medicines (also known as angiotensin II receptor blockers) ...
angiotensin ii receptor antagonists sartans article referral sartan medicines companies review en





Angiotensin-II- receptor antagonists (sartans) containing a tetrazole

20 sept. 2018 Referral under Article 31 of Directive 2001/83/EC Valsartan- containing medicinal products. We refer to the letter of the European Medicines ...
angiotensin ii receptor antagonists sartans article referral notification extension scope en


April 2019 CMDh press release

30 avr. 2019 Following the Art. 31 referral on angiotensin-II-receptor antagonists (sartans) containing a tetrazole group which concluded on strict ...
ciprofloxacin corr. cmdh presse anl ? blob=publicationFile&v=


248442
  1. art. 31 referral on angiotensin-ii-receptor antagonists (sartans)